May 12th, 2008
In a separate post, I already mentioned The Pathwork® Tissue of Origin Test.
It is interesting to know that Stanford University School of Medicine is investigating an investigational study of the this genomics-based diagnostic test for hard-to-identify tumors — The Pathwork® Tissue of Origin Test.
The new test uses advanced genomics-based technology to help physicians determine a […]
By Gloria Gamat -- 0 comments
May 8th, 2008
A product of Pathwork Diagnostics, The Pathwork® Tissue of Origin Test is designed to increase diagnostic certainty for hard-to-identify tumors.
The Pathwork® Tissue of Origin Test measures the expression of more than 1500 genes present in a tissue sample and generates the tumor’s gene expression profile. This profile is then compared to those of 15 known […]
By Gloria Gamat -- 1 comment
April 15th, 2008
This came to my attention a while back, but for some reason got buried in my inbox. So sorry Laura!
Two new oncology tests — classifying metastatic cancer and identifying patients with estrogen receptor positive (ER+) breast cancer who are at high risk of recurrence as well as unlikely to respond favorably to standard adjuvant […]
By Gloria Gamat -- 0 comments
March 7th, 2008
In late December 20106, former Yankee and current YES announcer Bobby Murcer was diagnosed with brain cancer.
Recently, a new MRI image revealed only a scar tissue and not a recurrence of cancer.
Well, that’s really good news, right?
There had been differing opinions among doctors about the meaning of the MRI, so as a precaution they scheduled […]
By Gloria Gamat -- 0 comments
February 20th, 2008
A blood test that has enough sensitivity and specificity to detect early stage ovarian cancer (cancer of the ovary) with 99 percent accuracy has been developed by Yale School of Medicine researchers.
According to Gil Mor, M.D., associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale:
“The ability to recognize almost 100 percent […]
By Gloria Gamat -- 1 comment
January 21st, 2008
What if you submitted yourself to various cancer tests and you are asked to undergo the same thing again because the hospital screwed up the samples?
I bet you’ll be angry! I will be too.
Like what this woman experienced n in a Welsh hospital.
Deborah Martin, 43, has been told three separate biopsies for breast and stomach […]
By Gloria Gamat -- 0 comments
January 19th, 2008
Speaking of prostate cancer, it is important to catch it early, as with any other type of cancer.
Early cancer detection increases response to treatment, the chance of curing the cancer and patient survival. Most especially, it may prevent the patient from undergoing surgery.
As we know, however advanced procedures there may have, surgery doesn’t come with […]
By Gloria Gamat -- 0 comments
January 18th, 2008
According to new genomics research by a team from Wake Forest University School of Medicine, a blood test for five generic variants previously associated with prostate cancer will be able to gauge a man’s risk for developing prostate cancer.
As the researchers reported in New England Journal of Medicine:
Researchers found that a man with four of […]
By Gloria Gamat -- 0 comments
January 15th, 2008
Approved by the FDA, a genetic test that can help in the assessment of risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer - TOP2A FISH pharmDx - is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients.
The TOP2A gene plays a role […]
By Gloria Gamat -- 1 comment
January 14th, 2008
The quantity and identity of specific protein markers in the human saliva can be used as an early, non-invasive diagnostic test for breast cancer that can even be conducted by dentists.
Such were the findings of a new study by researchers at The University of Texas Health Science Center at Houston.
The study describes how the onset […]
By Gloria Gamat -- 1 comment
Recent Comments